Riegel Announces Oral Presentation of Phase 1b Data for R289 in Patients with Low-Risk MDS at the American Society of Hematology's 68th Annual Meeting and Exposition - Society Announces.
🇺🇸 USA · Map
Riegel Announces Oral Presentation of Phase 1b Data for R289 in Patients with Low-Risk MDS at the American Society of Hematology's 68th Annual Meeting and Exposition - Society Announces.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in